Praxis Precision Medicines, Inc. furnished its press release dated February 19, 2026, under Item 2.02 as Exhibit 99.1, relating to results of operations. The filing includes references to analyst consensus EPS context for the period.
Key takeaways
Item 2.02 Results of Operations furnished, including Exhibit 99.1 Press Release dated 2026-02-19
Item 9.01 Financial Statements and Exhibits with Exhibit 99.1 and 104
Consensus EPS for 2026-02-19: $-3.50 vs estimate $-3.13 (-12.0%)
Prior consensus: 2025-11-05 EPS $-3.36 vs est $-3.45 (+2.6%)